Psychiatry and Neurology, Neurology · Winchester, VA
NPI
1063441533
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
905 Cedar Creek Grade, Suite 200
Winchester, VA, 22601
Phone (540) 722-8882
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
174,478 services
Medicare patients, 2024
1,394
Average age 74
Drug cost, 2024
$6.7M
1,109 prescriptions
Company payments, 2025
$116K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A Landrio was code J0174 (injection, lecanemab-irmb, 1 mg), 157,518 times for 18 patients. In total Mark A Landrio billed 174,478 services in 50 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 157,518 | 18 | $1.05 | $165K |
| J0897 Injection, denosumab, 1 mg | Office | 2,400 | 26 | $19.84 | $48K |
| 99214 Office E&M - Established | Office | 1,506 | 856 | $78.71 | $119K |
| 99215 Office E&M - Established | Office | 768 | 451 | $108.91 | $84K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 352 | 67 | $0.75 | $265 |
| 96413 Chemotherapy Administration | Office | 334 | 38 | $83.33 | $28K |
| 36415 Venipuncture Blood Collection | Office | 324 | 48 | $8.39 | $2,717 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 322 | 250 | $10.82 | $3,485 |
| 96366 Intravenous Infusion, Hydration | Office | 289 | 15 | $12.86 | $3,715 |
| 95886 Electrical Nerve Conductivity | Office | 265 | 251 | $65.71 | $17K |
| 99204 Office E&M - New | Office | 186 | 186 | $107.46 | $20K |
| 95911 Electrical Nerve Conductivity | Office | 160 | 160 | $138.52 | $22K |
| 96365 Intravenous Infusion, Hydration | Office | 142 | 17 | $38.59 | $5,480 |
| 96372 Injection Administration | Office | 131 | 54 | $9.34 | $1,224 |
| 95810 Sleep Study | Office | 120 | 115 | $421.04 | $51K |
By year: 2022 $529K for 5,255 services; 2023 $619K for 7,132 services; 2024 $1.6M for 174,478 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 324 | 48 | $8.39 | $2,717 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark A Landrio prescribed most often to Medicare patients was Octagam (Immun Globg(Igg)/Malt/Iga Ov50), with 174 prescriptions and refills. In total Mark A Landrio wrote 1,109 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 174 | 198 | 23 | $3.0M |
| Donepezil Hcl Generic | 86 | 140 | 28 | $617 |
| Duloxetine Hcl Generic | 84 | 124 | 25 | $968 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 45 | 86 | 14 | $583 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 35 | 35 | Under 11 | $307K |
| Topiramate Generic | 34 | 76 | 13 | $500 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 32 | 84 | 18 | $1,198 |
| Quetiapine Fumarate Generic | 32 | 33 | Under 11 | $259 |
| Clopidogrel Clopidogrel Bisulfate | 31 | 55 | 12 | $245 |
| Nortriptyline Hcl Generic | 26 | 48 | Under 11 | $248 |
| Memantine Hcl Generic | 24 | 47 | Under 11 | $439 |
| Propranolol Hcl Er Propranolol Hcl | 21 | 37 | Under 11 | $653 |
| Baclofen Generic | 21 | 31 | Under 11 | $195 |
| Gabapentin Generic | 19 | 23 | Under 11 | $91.62 |
| Vyvgart Hytrulo Efgartigimod-Hyaluronidas-Qvfc | 19 | 19 | Under 11 | $1.1M |
Brand drugs: 409 claims; generic drugs: 700 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark A Landrio $116K ($116K in general payments such as food, travel and fees) from 33 companies. The largest payer was EMD Serono, Inc. with $54K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 54 | $54K |
| UCB, Inc. UCB.BR | 24 | $20K |
| Alexion Pharmaceuticals, Inc. AZN | 31 | $18K |
| Argenx US, Inc. ARGX | 20 | $11K |
| Biogen, Inc. BIIB | 45 | $8,650 |
| TG Therapeutics, Inc. TGTX | 14 | $2,220 |
| Pfizer Inc. PFE | 27 | $278 |
| Eisai Inc. 4523.T | 12 | $253 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $195 |
| Amgen Inc. AMGN | 11 | $181 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.